ArticleAntimicrobial agents and chemotherapy2000
Bactericidal activities of antibiotics against intracellular Francisella tularensis.
Article in Antimicrobial agents and chemotherapy, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 72 citations in OpenAlex.
- Tularemia: Historical Perspectives and Current Challenges of a Re-Emerging Zoonosis.Biomedicines · 2026Review
- Development of Effective Medical Countermeasures Against the Main Biowarfare Agents: The Importance of Antibodies.Microorganisms · 2024Review
- Case Studies and Literature Review of Francisella tularensis-Related Prosthetic Joint Infection.Emerging infectious diseases · 2023Review
- Tularemia treatment: experimental and clinical data.Frontiers in microbiology · 2023Review
- In Vitro Antimicrobial Susceptibilities ofAntibiotics (Basel, Switzerland) · 2021Article
- TPR1, a novel rifampicin derivative, demonstrates efficacy alone and in combination with doxycycline against the NIAID Category A priority pathogenJAC-antimicrobial resistance · 2021Article
- The Polyaminoisoprenyl Potentiator NV716 Revives Old Disused Antibiotics against Intracellular Forms of Infection by Pseudomonas aeruginosa.Antimicrobial agents and chemotherapy · 2021Article
- Genetic Determinants of Antibiotic Resistance inFrontiers in microbiology · 2021Review
- Tetracyclines for Treatment of Tularemia: A Case Series.Open forum infectious diseases · 2018Article
- Review
- A rapid real-time quantitative PCR assay to determine the minimal inhibitory extracellular concentration of antibiotics against an intracellular Francisella tularensis Live Vaccine Strain.Frontiers in microbiology · 2015Article
- Bis-indolic compounds as potential new therapeutic alternatives for tularaemia.Frontiers in cellular and infection microbiology · 2014Article
- A new dye uptake assay to test the activity of antibiotics against intracellular Francisella tularensis.Frontiers in cellular and infection microbiology · 2014Article
- New therapeutic approaches for treatment of tularaemia: a review.Frontiers in cellular and infection microbiology · 2014Review
- Cell extract-containing medium for culture of intracellular fastidious bacteria.Journal of clinical microbiology · 2013Article
- Treatment of tularemia in pregnant woman, France.Emerging infectious diseases · 2013Article
- Francisella novicida bacteremia after a near-drowning accident.Journal of clinical microbiology · 2012Article
- Article
- Enhanced antibacterial effect of ceftriaxone sodium-loaded chitosan nanoparticles against intracellular Salmonella typhimurium.AAPS PharmSciTech · 2012Article
- In vitro and in vivo efficacy of florfenicol for treatment of Francisella asiatica infection in tilapia.Antimicrobial agents and chemotherapy · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
MICs of many antibiotics for Francisella tularensis are low in axenic medium, whereas only aminoglycosides, tetracyclines, and fluoroquinolones are useful in treating tularemic patients. In an in vitro cell system, only these antibiotics, rifampin, and telithromycin were bactericidal against intracellular F. tularensis. These results correlate better with clinical data than MIC data do.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.